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Abstract 109 – Table 1. Analyte associations with severity and progression of knee OA (adjusted for age, gender, and BMI)
Baseline Knee OA Severity Status Change () in Knee OA Severity Status†
Bone Scan JSN OST Pain  Bone Scan  JSN  OST  Pain
SF UA
Parameter Estimate 0.12 0.06 0.14 0.02 0.04 0.001 -0.02 -0.07
(95% CIs) (0.05/0.19) (0.003/0.12) (0.07/0.21) (0.03/0.07) (0.10/0.18) (0.03/0.03) (0.18/0.13) (0.15/0.0001)
p value* 0.001 0.06 <0.0001 0.41 0.58 0.97 0.77 0.05
SF ln IL-18
Parameter Estimate 0.57 0.01 0.45 0.14 0.23 0.04 0.46 -0.02
(95% CIs) (0.57/0.82) (0.01/0.03) (0.18/0.73) (0.02/0.25) (0.14/0.59) (-0.05 /0.13) (0.06/0.86) (0.21/0.17)
p value* <0.0001 0.15 0.001 0.02 0.22 0.40 0.02 0.84
SF ln IL-1β
Parameter Estimate 0.09 0.16 0.25 0.05 0.10 0.04 -0.37 0.03
(95% CIs) (0.67/0.08) (-0.72/-0.002) (0.11/0.40) (0.04/0.13) (0.24/0.45) (0.02/0.09) (0.89/0.15) (0.003/0.07)
p value* 0.12 0.049 0.001 0.28 0.55 0.18 0.16 0.07
JSN = joint space narrowing; OST = osteophyte; BMI = body mass index;  = change over 3 years in knee OA status. *P values adjusted by GLM (generalized linear modelling to control
for within subject correlation of knee data). †Additional adjustment for baseline OA status.
KL grade). All SF analytes correlated strongly with each other (Fig. 1).
The mean ± SD (range) concentrations of the cytokines were as follows:
IL-18 127.1±66.5 pg/ml (range 8.8-299.5), n=130; IL-1β 0.375±0.446 pg/ml
(range 0-1.589), n=48. In models adjusting for age, gender, and BMI, base-
line synovial ﬂuid uric acid, IL-18 and IL-1β all correlated independently
with x-ray features of OA represented by OST scores and IL-1β also corre-
lated with JSN (Table 1). Synovial ﬂuid UA and IL-18 also correlated strongly
with late phase bone scan scores (Table 1). IL-18 additionally correlated
with knee pain (Table 1). Three-year follow-up bone scans, radiographs and
pain scores were available for 37, 31, and 38 knees respectively. Models
were run using this 3 year follow-up subset to determine if the baseline
concentrations of synovial ﬂuid measures were associated with changes in
bone scans, radiographs, and pain over time (Table 1). Baseline IL-18 was
associated with 3-year change in OST scores. Baseline synovial ﬂuid uric
acid showed a borderline association with 3-year change in pain (p=0.05)
while IL-1β showed no associations.
Conclusions: This study shows that SF UA is a marker of joint inﬂammation
and OA severity. The correlation of SF UA with the two cytokines (IL-18
and IL-1β) known to be produced by UA activated inﬂammasomes and the
association of synovial ﬂuid IL-18 with OA progression lends strong support
to the potential involvement of the innate immune system in OA pathology
and progression.
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Purpose: The pathogenesis of osteoarthritis (OA) is complex including
structural and morphometric changes of several tissues. Cartilage loss and
overall bone remodeling are central in the progression of OA, and have been
studied in many ways including radiographs, magnetic resonance imaging
(MRI), and from systemic ﬂuids. Previous research has demonstrated the
superiority of a combination marker compared to single biomarkers in di-
agnosis of OA. In this study, we investigated a combination of a biochemical
marker with cartilage and bone structure markers from MRI for diagnosis
of OA.
Methods: The 21-month longitudinal study included 159 subjects prospec-
tively selected to include a large range of ages and degrees of OA. After
exclusion of scans due to acquisition errors, 311 knee scans were included.
The population characteristics were: age 56±16, BMI 26±4, 47% female,
and 19% with radiographic OA (Kellgren and Lawrence, KL>1). The KL score
was determined from load-bearing radiographs in semi-ﬂexed position
using the SynaFlex (Synarc). MRI scans with near-isotropic voxels were
acquired from a Turbo 3D T1 sequence from a 0.18T Esaote scanner (40°
FA, TR 50ms, TE 16 ms, scan time 10 minutes, resolution 0.7mm x 0.7mm x
0.8mm).
Urinary levels of collagen type II C-telopeptide fragments (uCTX-II) were
measured by the CartiLaps ELISA assay and corrected for urinary cre-
atinine levels. We used log(uCTX-II) to have approximately normally
distributed marker values. The cartilage MRI markers consisted of the
cartilage thickness, surface smoothness, volume, homogeneity (the entropy
of the cartilage intensity distribution), and surface curvature. They were all
quantiﬁed by a fully automatic, computer-based framework in the medial
tibial compartment. The bone structure MRI marker was quantiﬁed by a
machine learning system from a selection of 20 features extracted in a
region-of-interest in the subchondral medial tibia from 3 to 14 mm below
the cartilage covering a load-bearing region of the trabecular bone.
An aggregate biomarker was made by combining all biomarkers. They were
evaluated with respect to their ability to discriminate healthy and OA
knees by the area under the receiver-operator characteristics curve (AUC)
individually and in combination. The statistical signiﬁcances of AUC scores
and differences in-between were tested using DeLong’s test.
Results: The highest AUC among the single biomarkers was 0.79 for
the cartilage smoothness marker. The AUC for the combination marker
was 0.85, p=0.00059 which was signiﬁcantly better compared to cartilage
thickness, cartilage homogeneity, cartilage volume, and uCTX-II.
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Biomarker AUC P-value vs. aggregate
Cartilage thickness 0.60 0.008
Cartilage smoothness 0.79 0.33
Cartilage homogeneity 0.67 0.041
Cartilage volume 0.58 0.011
Cartilage curvature 0.76 0.24
uCTX-II 0.71 <0.001
Bone structure 0.77 0.075
Aggregate: All biomarkers 0.85 –
Conclusions: The complexity and heterogeneity of OA makes it unlikely
that a single marker will allow a comprehensive quantiﬁcation. Therefore,
aggregate markers based on measurements from different modalities and
targeting different anatomical structures could potentially be superior.
The results showed that the very different OA biomarkers each provided
some diagnostic ability. However, the aggregate combination marker was
superior and demonstrated the potential for multi-model markers. The
potential challenge of quantifying many markers was overcome by mainly
using fully automatic computer-based MRI markers allowing scalability to
large, multi-center studies.
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Purpose: Pain is the most prominent and disabling symptom of osteoarthri-
tis (OA). Despite its importance, much remains unknown about OA pain.
Current assessment methods for pain are subjectively evaluated by the
patients.
The gold standard for assessing joint damage is still the radiograph.
However, this method only provides a historical view of the damage, and
is rather insensitive and does not allow for the early detection of joint
damage. In addition, there are weak associations between pain severity and
radiographic change.
There is an urgent need for reliable, quantitative, and dynamic tests that
will detect early joint damage. Biomarkers, in addition to MRI, are expected
to be candidates that can detect the cartilage, bone and synovium turnover
for an objective and eﬃcient assessment of the joint damage in OA.
The present study sought to detect early-stage knee OA based on criteria
involving the presence of pain using the biomarkers.
Methods: The 46 subjects were enrolled in this study. Following the
traditional deﬁnition for OA, the subjects with the K/L 1 were diagnosed
as having an absence of OA and those with KL2 were diagnosed as having
knee OA. Pain in the knee was assessed using a visual analogue scale (VAS).
The biomarkers used were for serum collagen type II cleavage (sC2C),
synthesis of type II collagen carboxy propeptide (sCP II), hyaluronic acid
(sHA), urinary type II collagen C-telopeptide (uCTX-II/Cr), and N-terminal
crosslinking telopeptide of type I collagen (uNTx/Cr). The serum and urinary
levels of these biomarkers were applied to logarithmic transformation, and
they were adjusted for age, sex and body mass index for comparison. The
parametric comparisons used analysis of variance (ANOVA). A p<0.05 was
considered to be signiﬁcant.
Results: The 46 subjects consisted of 30 subjects with K/L 1 and 16 with
K/L 2. 16 subjects had knee pain, and remaining 30 subjects did not have
knee pain. The 30 subjects without knee pain consisted of 22 subjects with
K/L 1 and the 8 subjects with K/L 2. 8 subjects with knee pain showed
radiographic K/L 1 and, the remaining 8 showed K/L 2.
First, the subjects were divided into two groups according to the presence
or absence of a radiographic OA. No signiﬁcant differences of the sC2C,
uCTX-II/Cr and uNTx/Cr were observed between the subjects with K/L1
and those with K/L2. The sCPII in the subjects with K/L2 were signiﬁcantly
reduced in comparison to those with K/L2, while the sHA showed opposite.
Second, the subjects were divided into two groups according to the pres-
ence or absence of a knee pain. The sC2C, uCTX-II/Cr, sCPII and sHA were
signiﬁcantly increased in those with knee pain in comparison to those
without knee pain. No signiﬁcant differences of the uNTx/Cr were observed
between these two groups.
Third, the subjects were divided into four groups according to the presence
or absence of both radiographic knee OA and knee pain. The sC2C in the
subjects with K/L 1 and knee pain signiﬁcantly increased in comparison
to the subjects with K/L 1 and 2 without knee pain. The sCPII in the
subjects with K/L 1 and knee pain increased in comparison to those in
other three groups. The uCTX-II/Cr in the subjects with K/L 2 and knee pain
signiﬁcantly increased in comparison to those in the subjects with K/L 1
and 2 without knee pain. No signiﬁcant differences of the uNTx/Cr were
observed between these four groups. The sHA in the subjects with K/L 2
with and without knee pain signiﬁcantly increased in comparison to those
in the subjects with K/L 1 without knee pain.
Conclusions These results suggest that osteoarthritic knee pain in early-
stage knee OA, such as not only K/L 2 but also K/L 1, is associated with
metabolic changes revealed by these biomarkers, namely anabolic, catabolic
and inﬂammatory responses involving cartilage and probably synovium,
while it is not associated with gross radiographic changes of the knee and
how these changes trigger pain still remains unclear.
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Introduction: Standard morphometric cartilage parameters of volume and
average cartilage thickness have shown very low responsiveness to OA
progression, which limits their utility for OA clinical trials. However, a
novel automated atlas based standardized measurement method allows the
use of advance image analysis methodologies to quantify point by point
changes in cartilage thickness. The data from this point by point atlas based
process provides a more sensitive analysis of OA progression.
Objective: To evaluate the sensitivity of an atlas based standardized
measurement method to detect changes in articular cartilage thickness in
subjects with OA symptoms but no radiological evidence of OA.
Methods: The baseline, 12 month and 24 month DESS sagittal MRI knee
images of 133 subjects from the OAI progression cohort releases: 0.C.2,
1.C2, 3.C.1 were segmented to bones and articular cartilage using a fully
automated atlas based segmentation algorithm and a previously developed
anatomic atlas. All segmentations were evaluated for quality; 4 subjects
were removed due to large segmentation errors. Using the atlas deforma-
tions 3D map, all the cartilage thickness maps were mapped back to the
anatomic atlas, and were compared point by point to the atlas cartilage
thicknesses. After the thickness measurements were mapped onto the
atlas space, all cartilage measurements were compared to the baseline
measurement by a point by point subtraction. The change in thickness
values from baseline were statistically described by mean, variance and
percentiles of thickness change values for each subject and for each
cartilage plate. The quantiﬁcation was done on cMF, cLF, MT, LT, F, T,
medial WB, lateral WB and the entire tibia femoral joint (TF). The paired
KL scores of the 133 subjects and the JSN OARSI scores provided by the
OAI site (http://www.oai.ucsf.edu) were used to identify the subjects with
Table 1. The annualized change, the standard deviation of the residuals, the annualized
standard response of the mean (SRM) and the proportion of subjects that change mea-
surement from the 12 month to the 24 month visit are shown for the average cartilage
change, the standard difference of changes, and the average values of the lower 5% per-
centile of changes are shown for the different cartilage regions
*Statistically signiﬁcant form zero (p<0.05). ** are proportions statistically different from
0.5 (p<0.05)
